Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenocarcinoma × belinostat × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myeloid, Acute 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Recurrence 3 Myelodysplastic Syndromes 3 Mycosis Fungoides 3 Lymphoma, T-Cell 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Waldenstrom Macroglobulinemia 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Sezary Syndrome 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parathyroid Neoplasms 2 Otorhinolaryngologic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Mixed Tumor, Mesodermal 2 Mesothelioma, Cystic 2 Mesothelioma 2 Lymphoma, Mantle-Cell 2

Interventions

Fluorouracil 9 Gemcitabine 7 pembrolizumab 6 Irinotecan 6 Paclitaxel 5 Leucovorin 5 Carboplatin 5 Nivolumab 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Albumin-Bound Paclitaxel 3 vandetanib 2 spartalizumab 2 selinexor 2 osimertinib 2 folfirinox 2 Taxes 2 Ramucirumab 2 Radiation 2 Docetaxel 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 zolbetuximab 1 trastuzumab deruxtecan 1 trametinib 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04315155 2020-10-28

BENEFIT

University of Utah

Phase 1 Withdrawn

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡